Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Unipro's power generation in Q1 increased by 9%

4/30/25 UPRO

Magnit officially announced the acquisition of control in Azbuka Vkusa

4/30/25 MGNT

Nizhnekamskshina reported for 2024 by IFRS

4/30/25 NKSH

DEK reported for 3 months of 2025 by RAS

4/30/25 DVEC

Kamaz in Q1 increased truck output by 2.5%

4/30/25 KMAZ

Fix Price reported for 3 months of 2025 by IFRS

4/30/25 FIXP

Fix Price's LFL traffic in Q1 continued to decline

4/30/25 FIXP

Demand for Delimobil in Q1 decreased by 13%c

4/30/25 DELI

O'Key's Q1 revenue grew by 2.6%

4/30/25 OKEY

APRI reported for 3 months of 2025 by RAS

4/30/25 APRI